View in EDS

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.

Saved in:
Bibliographic Details
Title: Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Authors: Haas EJ; Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel., Angulo FJ; Pfizer, Collegeville, PA, USA., McLaughlin JM; Pfizer, Collegeville, PA, USA., Anis E; Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Hadassah Braun School of Public Health, Hebrew University, Jerusalem, Israel., Singer SR; Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Hadassah Braun School of Public Health, Hebrew University, Jerusalem, Israel., Khan F; Pfizer, Collegeville, PA, USA., Brooks N; Information Technology Department, Israel Ministry of Health, Jerusalem, Israel., Smaja M; Information Technology Department, Israel Ministry of Health, Jerusalem, Israel., Mircus G; Pfizer Pharmaceuticals Israel, Herzliya, Israel., Pan K; Pfizer, Collegeville, PA, USA., Southern J; Pfizer, Collegeville, PA, USA., Swerdlow DL; Pfizer, Collegeville, PA, USA., Jodar L; Pfizer, Collegeville, PA, USA., Levy Y; Israel Ministry of Health, Jerusalem, Israel., Alroy-Preis S; Public Health Services, Israel Ministry of Health, Jerusalem, Israel. Electronic address: sharon.alroy@moh.gov.il.
Source: Lancet (London, England) [Lancet] 2021 May 15; Vol. 397 (10287), pp. 1819-1829. Date of Electronic Publication: 2021 May 05.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33964222
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Haas+EJ%22">Haas EJ</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Angulo+FJ%22">Angulo FJ</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22McLaughlin+JM%22">McLaughlin JM</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Anis+E%22">Anis E</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Hadassah Braun School of Public Health, Hebrew University, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Singer+SR%22">Singer SR</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Hadassah Braun School of Public Health, Hebrew University, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Khan+F%22">Khan F</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Brooks+N%22">Brooks N</searchLink>; Information Technology Department, Israel Ministry of Health, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Smaja+M%22">Smaja M</searchLink>; Information Technology Department, Israel Ministry of Health, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Mircus+G%22">Mircus G</searchLink>; Pfizer Pharmaceuticals Israel, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Pan+K%22">Pan K</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Southern+J%22">Southern J</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Swerdlow+DL%22">Swerdlow DL</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Jodar+L%22">Jodar L</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Levy+Y%22">Levy Y</searchLink>; Israel Ministry of Health, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Alroy-Preis+S%22">Alroy-Preis S</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel. Electronic address: sharon.alroy@moh.gov.il.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2021 May 15; Vol. 397 (10287), pp. 1819-1829. <i>Date of Electronic Publication: </i>2021 May 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33964222
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(21)00947-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1819
    Titles:
      – TitleFull: Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Haas EJ
      – PersonEntity:
          Name:
            NameFull: Angulo FJ
      – PersonEntity:
          Name:
            NameFull: McLaughlin JM
      – PersonEntity:
          Name:
            NameFull: Anis E
      – PersonEntity:
          Name:
            NameFull: Singer SR
      – PersonEntity:
          Name:
            NameFull: Khan F
      – PersonEntity:
          Name:
            NameFull: Brooks N
      – PersonEntity:
          Name:
            NameFull: Smaja M
      – PersonEntity:
          Name:
            NameFull: Mircus G
      – PersonEntity:
          Name:
            NameFull: Pan K
      – PersonEntity:
          Name:
            NameFull: Southern J
      – PersonEntity:
          Name:
            NameFull: Swerdlow DL
      – PersonEntity:
          Name:
            NameFull: Jodar L
      – PersonEntity:
          Name:
            NameFull: Levy Y
      – PersonEntity:
          Name:
            NameFull: Alroy-Preis S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 05
              Text: 2021 May 15
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 397
            – Type: issue
              Value: 10287
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1